Moderna Borrows $2 Billion To Expand Oncology Business
In brief
Moderna’s $2 billion convertible note deal aims to fund oncology growth while managing dilution, but the market reacted negatively, pushing shares down.
ClearTape summarizes context in-app. For the full publisher article, use Read original source above.